Old Web
English
Sign In
Acemap
>
authorDetail
>
A Blaukat
A Blaukat
Cancer research
Cetuximab
Epidermal growth factor receptor
Molecular biology
Biology
4
Papers
91
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficient Eradication of NSCLC by Combined DNAPK Inhibition and Carbon Ion Radiotherapy via Modulation of Tumor Invasion and Microenvironment - Beyond Direct Radiosensitization
2020
International Journal of Radiation Oncology Biology Physics
Ivana Dokic
Carmen Klein
M. Moustafa
S. Meister
S Mein
Benedikt Kopp
T. Tessonnier
S. Hasheminasab
Quanxiang Wei
J. Schlegel
Ali Nowrouzi
Christian Schwager
A. Mairani
A. Zimmermann
Frank Zenke
A Blaukat
Jürgen Debus
Amir Abdollahi
Show All
Source
Cite
Save
Citations (0)
Trimodal Therapy Consisting of DNA-PK Inhibition, PD-L1 Immune Checkpoint Blockade and Radiotherapy with Carbon Ions
2020
International Journal of Radiation Oncology Biology Physics
Carmen Klein
J. Schlegel
M. Knoll
Ivana Dokic
M. Moustafa
A. Mairani
S. Brons
A. Zimmermann
Frank Zenke
A Blaukat
Jürgen Debus
Amir Abdollahi
Show All
Source
Cite
Save
Citations (0)
Peptide mimotopes recognized by antibodies cetuximab and matuzumab induce a functionally equivalent anti-EGFR immune response
2010
Oncogene
C. Hartmann
Nina Müller
A Blaukat
Joachim Koch
Itai Benhar
Winfried S. Wels
Show All
Source
Cite
Save
Citations (31)
EGFR kinase domain mutations – functional impact and relevance for lung cancer therapy
2007
Oncogene
D Irmer
J O Funk
A Blaukat
Show All
Source
Cite
Save
Citations (60)
1